Open AccessRisk Group and Death From Prostate Cancer
Author(s) -
Ann C. Raldow,
Danjie Zhang,
MingHui Chen,
Michelle H. Braccioforte,
Brian J. Moran,
Anthony V. D’Amico
Publication year - 2015
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2014.284
Subject(s) - medicine , brachytherapy , hazard ratio , prostate cancer , proportional hazards model , cohort , gynecology , cancer , prospective cohort study , risk assessment , oncology , confidence interval , radiation therapy , computer security , computer science
Active surveillance (AS), per the National Comprehensive Cancer Network (NCCN) guidelines, is considered for patients with low-risk prostate cancer (PC) and a life expectancy of at least 10 years. However, given the grade migration following the 2005 International Society of Urologic Pathology consensus conference, AS may be appropriate for men presenting with favorable intermediate-risk PC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom